D L Kolesnik Selected Research

Lewis Lung Carcinoma

10/2023	EFFECT OF LACTATE DEHYDROGENASE INHIBITION BY OXAMATE ON LEWIS LUNG CARCINOMA CELLS WITH DIFFERENT METASTATIC POTENTIAL.
4/2021	The effect of 2D tungsten disulfide nanoparticles on Lewis lung carcinoma cells in vitro.
1/2021	Oxamate, an inhibitor of lactate dehydrogenase, can stimulate M2 polarization of peritoneal macrophages in mice with Lewis lung carcinoma.
1/2020	Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
1/2020	Tumor microenvironment changes tumor cell sensitivity to action of energy metabolism modifiers.
3/2019	Time-dependent cytotoxicity of dichloroacetate and metformin against Lewis lung carcinoma.
7/2017	Impact of lactic acidosis on the survival of Lewis lung carcinoma cells.
9/2016	2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma.
12/2015	Effect of enterosorption on paraneoplastic syndrome manifestations in mice with highly angiogenic variant of Lewis lung carcinoma.
3/2014	Dynamics of changes of antioxidant system indexes during the growth of two Lewis lung carcinoma variants.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D L Kolesnik Research Topics

Disease

16	Neoplasms (Cancer) 10/2023 - 09/2007
11	Lewis Lung Carcinoma 10/2023 - 09/2007
5	Glioma (Gliomas) 01/2019 - 12/2014
4	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2007
2	Hypoxia (Hypoxemia) 06/2016 - 12/2014
1	Circulating Neoplastic Cells 01/2020
1	Diabetes Mellitus 12/2017
1	Lactic Acidosis 07/2017
1	Acidosis 07/2017
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 12/2015
1	Carcinoma (Carcinomatosis) 09/2015
1	Body Weight (Weight, Body) 06/2015
1	Necrosis 12/2014
1	Hyperoxia 12/2014
1	Malnutrition (Nutritional Deficiencies) 12/2008

Drug/Important Bio-Agent (IBA)

9	Lactic Acid (Lactate)FDA LinkGeneric 10/2023 - 12/2014
7	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 12/2008
6	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 12/2017
5	Dichloroacetic AcidIBA 01/2020 - 06/2016
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2023 - 12/2014
4	Oxygen (Dioxygen)IBA 03/2019 - 12/2014
3	IronIBA 01/2020 - 03/2014
3	Heme (Haem)IBA 01/2020 - 03/2014
3	Cytostatic AgentsIBA 01/2020 - 12/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2016 - 03/2014
3	EnzymesIBA 06/2015 - 09/2007
2	SodiumIBA 10/2023 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 06/2016
2	Trypan Blue FDA Link 06/2015 - 12/2014
1	SuspensionsIBA 04/2021
1	tungsten sulfideIBA 04/2021
1	ArginaseIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	SulfurIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Hemeproteins (Heme Protein)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2017
1	Deoxyglucose (2 Deoxy D glucose)IBA 09/2016
1	Fluorescein-5-isothiocyanate (FITC)IBA 09/2016
1	CarbonIBA 12/2015
1	Angiogenesis InhibitorsIBA 09/2015
1	AconitineIBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 06/2015
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 12/2014
1	PlasticsIBA 12/2014
1	Coloring Agents (Dyes)IBA 12/2014
1	AntioxidantsIBA 03/2014
1	Superoxide DismutaseIBA 03/2014
1	Cisplatin (Platino)FDA LinkGeneric 09/2007
1	ImmunosorbentsIBA 09/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2007

Therapy/Procedure

5	Therapeutics 01/2020 - 12/2015
4	Cell Transplantation 10/2018 - 12/2015
2	Transplantation 01/2021 - 06/2015
1	Enterosorption 12/2015